The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application innovators in drug discovery, biomanufacturing, genomics, nanotechnology, and cell therapy.
Meet with the below Lumanity staff at the conference:
- Ed Saltzman, Head , Biotech Strategy
- Ginger Johnson, PhD, President, BioConsulting
- Jeffrey Bockman, PhD, Executive Vice President, BioConsulting, Head of Oncology
- Beth Fordham-Meier, Vice President, Business Development, Head, Corporate & Partnering Strategy Practice, BioConsulting
- Michael Rice, MS, MBA, Senior Vice President, BioConsulting, Head of Advanced Therapeutics and Rare Disease
- David Lomb, PhD, Principal, Autoimmune and Inflammatory Disease Co-Lead
Presentations at BIO
Early Scientific and Clinical Strategy for Optimizing Value Inflection in Oncology Financing and Dealmaking
June 13, 2022 @ 1:00PM // Upper Level, Session Room 6C
Moderated by: Jeffrey Bockman, PhD, Executive Vice President, BioConsulting, Head of Oncology
Panelists:
- Eric Rowinsky, CMO Hummingbird
- Mai-Britt Zocca, IO Biotech Founder and CEO
- Rachael Lester, SVP BD Harpoon Therapeutics
- Sharon Benzeno, Chief BD Officer, Adaptive Technologies
Trends, Challenges and Opportunities of Epigenetic Therapeutics in Cancer
June 14, 2022 @ 3:00PM // Upper Level, Session Room 6C
Panelists:
- Jeff Bockman, EVP, BioConsulting, Head of Oncology, Lumanity
- Thomas Paul, Senior Director, Pfizer La Jolla Laboratories
- Henry Long, Scientific Director, Center for Functional Cancer Epigenetics, DFCI
Women in Bio Entrepreneur Center and California Life Sciences Founders Panel Discussion
June 16, 2022 @ 11:00AM – 12:00PM
BioProcess Zone Theater – Booth #919
Moderated by: Ginger Johnson, President, BoConsulting and CNS Co-Lead